Medpace Holdings, Inc.MEDPNASDAQ
Loading
EV/EBITDA Over TimeExpanding
Percentile Rank92
3Y CAGR+6.1%
5Y CAGR+1.7%
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

3Y CAGR
+6.1%/yr
vs +14.0%/yr prior
5Y CAGR
+1.7%/yr
Recent acceleration
Acceleration
-7.8pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
202527.97+36.4%
202420.51-20.0%
202325.65+9.7%
202223.39-31.3%
202134.02+32.3%
202025.72+32.1%
201919.47+40.5%
201813.86-4.6%
201714.52+2.1%
201614.22-